Author

Mariana Pelicano de Almeida

Maastricht UniversityPrimary ORCID profile (0009-0001-4373-4982 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Mariana Pelicano de AlmeidaiD1 paper · Erasmus MC

Biology Disciplines

Click to filter author papers

Bioinformatics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:benchmark study· 1 Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1

Frequent Co-Authors

Albert A. AntolíniD· 1 shared Alberto CalderoneiD· 1 shared Alicia AmadoziD· 1 shared Amin AllamiD· 1 shared Amir B. K. ForoushaniiD· 1 shared Anastasios DrosouiD· 1 shared André O. FalcãoiD· 1 shared Andreas Bender· 1 shared

Activity by Year

2019-2019 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioinformatics

Albert A. AntolínORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

BioinformaticsNature CommunicationsPeer-reviewedJun 17, 2019

A cancer pharmacogenomic screen powering crowd-sourced advancement of drug combination prediction

Michael P. Menden, Dennis Y.Q. Wang, Mike J. Mason…·Denis Fourches

The paper presents a large-scale cancer pharmacogenomic screen with 11,576 experiments on 910 drug combinations across 85 cancer cell lines, enabling crowd-sourced prediction of synergistic drug pairs and biomarkers.

363 citationstop 1%

humanbulk RNA-seq

𝕏 PostBluesky